Ars Pharmaceuticals Inc (SPRY)

01:57 AM

ARS Pharmaceuticals Inc. Stock Analysis and ForecastBreakthrough financial growth - PrintWeekIndia

01:57 AM

Jul 24, 2025

Is ARS Pharmaceuticals Inc. a good long term investmentTriple-digit return opportunities - PrintWeekIndia

Jul 24, 2025

Jul 23, 2025

What drives ARS Pharmaceuticals Inc. stock priceTremendous growth opportunities - Autocar Professional

Jul 23, 2025

Jul 22, 2025

What analysts say about ARS Pharmaceuticals Inc. stockBreakthrough stock performance - jammulinksnews.com

Jul 22, 2025

Jul 18, 2025

MHRA approves needle-free adrenaline nasal spray for anaphylaxis - Yahoo Finance

Jul 18, 2025

Jul 18, 2025

EURneffy® (adrenaline nasal spray) Approved in the U.K. as - GlobeNewswire

Jul 18, 2025

Jul 18, 2025

EURneffy® (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis) - Yahoo Finance

Jul 18, 2025

Jul 15, 2025

ARS Pharmaceuticals, Inc. (SPRY) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

Jul 15, 2025

Jul 15, 2025

Wall Street Analysts See a 78.77% Upside in ARS Pharmaceuticals, Inc. (SPRY): Can the Stock Really Move This High? - Yahoo Finance

Jul 15, 2025

Jul 15, 2025

What Makes ARS Pharmaceuticals, Inc. (SPRY) a Good Fit for 'Trend Investing' - Yahoo Finance

Jul 15, 2025

Jul 10, 2025

ARS Pharmaceuticals: High Risk High Reward Rollout Of No Needle Epinephrine (SPRY) - Seeking Alpha

Jul 10, 2025

Jul 09, 2025

(SPRY) Technical Data - news.stocktradersdaily.com

Jul 09, 2025

Jul 09, 2025

ARS Pharmaceuticals: 'Betting On The Come' (NASDAQ:SPRY) - Seeking Alpha

Jul 09, 2025

Jul 03, 2025

ARS Pharmaceuticals: Insider Liquidity vs. Institutional Buying – A Contrarian Opportunity? - AInvest

Jul 03, 2025

Jul 01, 2025

ARS Pharmaceuticals: Navigating Insider Sales Amid Growth Catalysts - AInvest

Jul 01, 2025

Jun 30, 2025

Raymond James reiterates strong buy on ARS Pharmaceuticals stock - Investing.com India

Jun 30, 2025

Jun 27, 2025

ARS Pharmaceuticals (SPRY) Soars 4.48% on Earnings, Partnership - AInvest

Jun 27, 2025

Jun 26, 2025

ARS Pharmaceuticals Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 26, 2025

Jun 23, 2025

High Growth Tech Stocks in US for June 2025 - simplywall.st

Jun 23, 2025

Jun 21, 2025

Ars pharma CCO Karas sells $240k in SPRY stock - Investing.com India

Jun 21, 2025

Jun 18, 2025

Learn to Evaluate (SPRY) using the Charts - news.stocktradersdaily.com

Jun 18, 2025

Jun 18, 2025

ARS Pharmaceuticals | 6/18/25 - ktnv.com

Jun 18, 2025

Jun 18, 2025

FDA Reviewing Oral Epinephrine Film for Possible Approval - Allergic Living

Jun 18, 2025

Jun 17, 2025

Asthma Market to Expand Significantly by 2034, States - openPR.com

Jun 17, 2025

Jun 17, 2025

Asthma Market to Expand Significantly by 2034, States DelveInsight Report | GSK, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma, Genentech - Barchart.com

Jun 17, 2025

Jun 15, 2025

ARS Pharmaceuticals signs agreement with ALK-Abelló A/S for neffy - MSN

Jun 15, 2025

Jun 15, 2025

Jim Cramer on ARS Pharmaceuticals: “It’s a Great Flier” - Insider Monkey

Jun 15, 2025

Jun 12, 2025

Jim Cramer Discussed These 16 Stocks Recently - Insider Monkey

Jun 12, 2025